← All trials
NCT06513533
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 23, 2024
- Primary completion
- Mar 31, 2028
- Completion date
- Jun 30, 2028
- First posted
- Jul 22, 2024
- Last posted
- Jul 25, 2024
- Enrollment
- 40
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Onofre, Aurora Pujol, M.D.Lead sponsor
- Universidad Carlos III MadridCollaborator
- University of BarcelonaCollaborator
- Spanish Clinical Research NetworkCollaborator
- University of BarcelonaOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.